期 |
栏目 |
标题 |
文件 |
卷 19, 编号 3 (2017) |
Articles |
Regorafenib: from clinical research to clinical practice |
(Rus)
|
卷 20, 编号 1 (2018) |
Articles |
Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus |
(Rus)
|
卷 21, 编号 3 (2019) |
Articles |
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis |
|
卷 22, 编号 1 (2020) |
CLINICAL ONCOLOGY |
The effect of local immunity on gastric cancer prognosis |
(Rus)
|
卷 23, 编号 2 (2021) |
CLINICAL ONCOLOGY |
The identification of tumor-infiltrating lymphocytes in patients with stomach cancer |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Gastric cancer: Russian clinical guidelines |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON |
(Rus)
|
卷 26, 编号 1 (2024) |
Articles |
Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment |
(Rus)
|